Neuroprotective Agents [Pharmacological Action]
Tree Number(s): D018696
MeSH Unique ID: D018696
- tempol (Supplementary Concept)
- cerebrolysin (Supplementary Concept)
- tenocyclidine (Supplementary Concept)
- vinpocetine (Supplementary Concept)
- 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP (Supplementary Concept)
- nizofenone (Supplementary Concept)
- 4-methylcatechol (Supplementary Concept)
- 1-aminocyclopropane-1-carboxylic acid (Supplementary Concept)
- 3-aminobenzamide (Supplementary Concept)
- 3-n-butylphthalide (Supplementary Concept)
- isospaglumic acid (Supplementary Concept)
- fructose-1,6-diphosphate (Supplementary Concept)
- phenyl-N-tert-butylnitrone (Supplementary Concept)
- rasagiline (Supplementary Concept)
- propentofylline (Supplementary Concept)
- rimcazole (Supplementary Concept)
- 1-amino-1,3-dicarboxycyclopentane (Supplementary Concept)
- almitrine, raubasine drug combination (Supplementary Concept)
- ethylisopropylamiloride (Supplementary Concept)
- nitroxyl (Supplementary Concept)
- ebselen (Supplementary Concept)
- epigallocatechin gallate (Supplementary Concept)
- N-(1-methyl-2-phenylethyl)adenosine (Supplementary Concept)
- ACTH (4-7), Pro-Gly-Pro- (Supplementary Concept)
- huperzine A (Supplementary Concept)
- tirilazad (Supplementary Concept)
- RS 5186 (Supplementary Concept)
- 7-chlorokynurenic acid (Supplementary Concept)
- eliprodil (Supplementary Concept)
- nefiracetam (Supplementary Concept)
- linopirdine (Supplementary Concept)
- GYKI 52466 (Supplementary Concept)
- HU 211 (Supplementary Concept)
- U 78517F (Supplementary Concept)
- enadoline (Supplementary Concept)
- remacemide (Supplementary Concept)
- N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline (Supplementary Concept)
- gacyclidine (Supplementary Concept)
- neurotrophin 5 (Supplementary Concept)
- neurotrophin 4 (Supplementary Concept)
- U 74389F (Supplementary Concept)
- 4-carboxy-3-hydroxyphenylglycine (Supplementary Concept)
- ziconotide (Supplementary Concept)
- (3-aminopropyl)(n-butyl)phosphinic acid (Supplementary Concept)
- aptiganel (Supplementary Concept)
- 7-nitroindazole (Supplementary Concept)
- sipatrigine (Supplementary Concept)
- 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (Supplementary Concept)
- H290-51 (Supplementary Concept)
- benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone (Supplementary Concept)
- lubeluzole (Supplementary Concept)
- 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine (Supplementary Concept)
- ethyl phenylacetyl-Pro-Gly (Supplementary Concept)
- astressin (Supplementary Concept)
- AM 36 (Supplementary Concept)
- otaplimastat (Supplementary Concept)
- 5-imino-1,2,4-thiadiazole VP1.14 (Supplementary Concept)
- tricyclic pyrones (Supplementary Concept)
- DJ-1 based peptide, ND-13 (Supplementary Concept)
- DRalpha1-MOG-35-55 (Supplementary Concept)
- mesedin (Supplementary Concept)
- 7-((1-alkylpiperidin-3-yl)methoxy)coumarin (Supplementary Concept)
- HM01 (Supplementary Concept)
- emopag (Supplementary Concept)
- Meclofenoxate (MeSH Term)
- Chlormethiazole (MeSH Term)
- Dextrorphan (MeSH Term)
- Methylprednisolone (MeSH Term)
- Methylprednisolone Hemisuccinate (MeSH Term)
- Piracetam (MeSH Term)
- Selegiline (MeSH Term)
- Vasoactive Intestinal Peptide (MeSH Term)
- Dizocilpine Maleate (MeSH Term)
- Riluzole (MeSH Term)
- S-Nitrosoglutathione (MeSH Term)
- Rivastigmine (MeSH Term)
- Cilostazol (MeSH Term)
- Edaravone (MeSH Term)